Why the study?
Myocardial fibrosis is linked to adverse cardiac events, making early non-invasive quantitative detection important for risk stratification and clinical management.
Can strain imaging techniques be used for the non-invasive assessment and early detection of myocardial fibrosis in cardiovascular diseases?
Can strain imaging techniques be used for the non-invasive assessment and early detection of myocardial fibrosis in cardiovascular diseases?
Strain imaging techniques offer a promising non-invasive approach for the early detection and quantitative assessment of myocardial fibrosis.
Answers are grounded in this paper and cite their sources.
May aid fibrosis assessment in research; leaves open need for prospective validation before clinical adoption.
Myocardial fibrosis (MF) is a non-reversible process that occurs following acute or chronic myocardial damage. MF worsens myocardial deformation, remodels the heart and raises myocardial stiffness, and is a crucial pathological manifestation in patients with end-stage cardiovascular diseases and closely related to cardiac adverse events. Therefore, early quantitative analysis of MF plays an important role in risk stratification, clinical decision, and improvement in prognosis. With the advent and development of strain imaging modalities in recent years, MF may be detected early in cardiovascular diseases. This review summarizes the clinical usefulness of strain imaging techniques in the non-invasive assessment of MF.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: